Concentric Capital Strategies’s Thermo Fisher Scientific TMO Stock Holding History

Concentric Capital Strategies’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.6M	Buy	3,183 +2,168	+214%	+$1.04M	0.09%	191
2026 Q1	$499K	Buy	1,015 +638	+169%	+$346K	0.04%	218
2025 Q4	$218K	Sell	377 -65	-15%	-$36.8K	0.01%	248
2025 Q3	$214K	Buy	+442	New	+$206K	0.01%	293
2024 Q4	–	Sell	-13,278	Closed	-$8.21M	–	363
2024 Q3	$8.21M	Buy	13,278 +12,009	+946%	+$7.11M	0.34%	72
2024 Q2	$702K	Sell	1,269 -2,555	-67%	-$1.46M	0.04%	265
2024 Q1	$2.22M	Buy	3,824 +3,068	+406%	+$1.72M	0.13%	179
2023 Q4	$401K	Sell	756 -201	-21%	-$97.3K	0.05%	178
2023 Q3	$484K	Buy	+957	New	+$510K	0.05%	163

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Concentric Capital Strategies's TMO Position: Q2 2026 in Review

Concentric Capital Strategies increased its Thermo Fisher Scientific (TMO) stake by 214% in Q2 2026, buying an estimated $1.04M and bringing the position to 3,183 shares worth $1.6M. The position accounts for 0.09% of the portfolio, ranked #191.

Concentric Capital Strategies first reported a position in TMO in Q3 2023 and has held it in 9 quarters since. The position peaked at $8.21M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Concentric Capital Strategies held 3,183 shares of Thermo Fisher Scientific worth $1.6M as of Q2 2026.
Concentric Capital Strategies bought 2,168 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.04M.
Thermo Fisher Scientific made up 0.09% of Concentric Capital Strategies's portfolio in Q2 2026, its #191 holding.
Concentric Capital Strategies first reported a position in Thermo Fisher Scientific in Q3 2023 and has held it in 9 quarters since.
Concentric Capital Strategies's Thermo Fisher Scientific position peaked at $8.21M in Q3 2024.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Concentric Capital Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.